Skip to main navigation
Bolt
  • About
    • Management Team
    • Board of Directors
  • Partnering
    • Boltbody™ ISAC Platform
    • BDC-3042
    • CEA ISAC
    • PD-L1 ISAC
    • Publications
  • Pipeline
    • BDC-4182
    • Publications
  • Patients
  • Careers
  • Investors & Media
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • SEC Filings
    • Resources
      • Email Alerts
      • Contact IR
  • Menu Menu

Event Details

2024 Society of Immunotherapy of Cancer (SITC) Annual Meeting

November 6 - November 10, 2024

Supporting Materials

Key Learnings from BDC-1001 SITC Poster 4.8 MB
Key Learnings from BDC-1001 Oral Presentation 2.8 MB
BDC-4182 SITC Poster 906.3 KB
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
Bolt Biotherapeutics, Inc

900 Chesapeake Drive
Redwood City, CA 94063
Phone: 650.665.9295
info@boltbio.com

 

You acknowledge that the personal information you provide to Bolt Biotherapeutics will be processed to respond to your request or inquiry. For more information, please review our Privacy Notice.

 

  Manage Cookie Preferences
© 2026 - Bolt Biotherapeutics - All rights reserved.
  • Terms of Use
  • Privacy Notice
Scroll to top